QRG Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Buy
3,550
+451
+15% +$55.4K ﹤0.01% 873
2026
Q1
$365K Buy
3,099
+52
+2% +$7.26K ﹤0.01% 883
2025
Q4
$499K Buy
3,047
+626
+26% +$98K 0.01% 762
2025
Q3
$324K Sell
2,421
-81
-3% -$9.84K ﹤0.01% 858
2025
Q2
$311K Sell
2,502
-46
-2% -$5.85K ﹤0.01% 953
2025
Q1
$324K Buy
2,548
+206
+9% +$31.7K ﹤0.01% 895
2024
Q4
$337K Sell
2,342
-1,300
-36% -$186K ﹤0.01% 876
2024
Q3
$542K Buy
3,642
+406
+13% +$58.2K 0.01% 751
2024
Q2
$408K Sell
3,236
-340
-10% -$53.3K ﹤0.01% 789
2024
Q1
$658K Buy
3,576
+850
+31% +$162K 0.01% 666
2023
Q4
$490K Sell
2,726
-64
-2% -$9.96K 0.01% 723
2023
Q3
$444K Buy
+2,790
New +$456K 0.01% 700

Other funds holding RGEN

QRG Capital Management's RGEN Position: Q2 2026 in Review

QRG Capital Management increased its Repligen (RGEN) stake by 15% in Q2 2026, buying an estimated $55.4K and bringing the position to 3,550 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #873.

QRG Capital Management first reported a position in RGEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $658K in Q1 2024. 59 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • QRG Capital Management held 3,550 shares of Repligen worth $484K as of Q2 2026.
  • QRG Capital Management bought 451 Repligen shares in Q2 2026, an estimated $55.4K.
  • Repligen made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #873 holding.
  • QRG Capital Management first reported a position in Repligen in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Repligen position peaked at $658K in Q1 2024.
  • 59 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.